Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for Coronary Flow Reserve in Diabetic Patients
NCT01754259Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranolazine in angina pectoris, coronary artery disease (CAD), sponsored by Brigham and Women's Hospital. Started Apr 2013; status: completed.
02
Drugs
ranolazine
03
Conditions
angina pectoriscoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01754259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01754259.